» Articles » PMID: 22790470

Treating Primary Hypothyroidism with Weekly Doses of Levothyroxine: a Randomized, Single-blind, Crossover Study

Overview
Specialty Endocrinology
Date 2012 Jul 14
PMID 22790470
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Compliance to levothyroxine treatment in hypothyroidism is compromised by daily schedule, and a weekly dose may be an alternative.

Subjects And Methods: This was a randomized, crossover study. Fourteen females were assigned to daily or weekly doses of LT4. After six weeks, they switched regimens. Thyroid parameters were measured at baseline, and after 42 and 84 days. Echocardiogram and hyperthyroidism symptoms were evaluated before and four hours after LT4 intake.

Results: In the weekly dose treatment, fT4 levels were higher after taking LT4, and lower seven days after the last dose; by the 6(th) week there was a small decrease in T3 levels. TSH remained unchanged and there were no hyperthyroidism symptoms or echocardiographic manifestations.

Conclusion: Weekly dose leads to transient increases in fT4, without hyperthyroidism or cardiac symptoms. That approach seems to be a safe alternative for the treatment of hypothyroidism.

Citing Articles

Twice or thrice weekly levothyroxine provides similar rates of adherence and post-Ramadan euthyroidism compared to daily levothyroxine during Ramadan fasting.

Elsherbiny T Thyroid Res. 2023; 16(1):44.

PMID: 38053151 PMC: 10698921. DOI: 10.1186/s13044-023-00187-z.


Assessing the cardiovascular effects of levothyroxine use in an ageing United Kingdom population (ACEL-UK) protocol: a cohort and target trial emulation study.

Holley M, Razvi S, Dew R, Maxwell I, Wilkes S Thyroid Res. 2023; 16(1):43.

PMID: 37953303 PMC: 10641939. DOI: 10.1186/s13044-023-00186-0.


Approach to adult patients with primary hypothyroidism in some special situations: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).

da Silva Mazeto G, Sgarbi J, Ramos H, Villagelin Neto D, Nogueira C, Vaisman M Arch Endocrinol Metab. 2022; 66(6):871-882.

PMID: 36394484 PMC: 10118754. DOI: 10.20945/2359-3997000000545.


Twice or Thrice Weekly versus Daily Thyroxine in Hypothyroid Fasting Ramadan: A Pilot Study.

Elsherbiny T Indian J Endocrinol Metab. 2022; 26(3):265-268.

PMID: 36248049 PMC: 9555373. DOI: 10.4103/ijem.ijem_1_22.


A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal.

Ducharme M, Scarsi C, Bettazzi E, Mautone G, Lewis Y, Celi F Thyroid. 2022; 32(8):897-904.

PMID: 35469428 PMC: 9419984. DOI: 10.1089/thy.2021.0604.